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Background
Troponin assays have an established role in the diagnosis
and risk stratification of patients with acute coronary
syndromes. The lack of an accurate diagnosis and the
uncertain prognosis when obstructive coronary disease is
absent represents a clinical challenge. We sought to
describe the distribution of late gadolinium enhancement
(LGE) and its impact on hospital readmission and death
in patients with raised high-sensitivity troponin
T (hsTnT) not attributed to an acute coronary syndrome.
Methods
1.5T (n=92) and 3.0T (n=14) cardiac magnetic reso-
nance (CMR) studies and clinical records of 106 patients
(mean age 50 years, 37% female) referred by their
attending cardiologist were retrospectively assessed.
CMR evaluation included left ventricular (LV) volumes
and LGE in all patients at an average of 10 days of first
hsTnT elevation (≥15ng/L). Patients with obstructive
coronary disease (stenosis ≥50%) by coronary angiogra-
phy were excluded. Hospital readmission and all-cause
mortality one-year following the index CMR were
assessed.
Results
The most common presenting symptoms were chest
pain (n=67) and dyspnea (n=38); 11 patients presented
with cardiac arrest. Presenting ECG documented ST ele-
vation (n=30), ST-segment depression (n=19) and T-
wave inversion (n=32). The mean peak hsTnT was
735ng/L (15-15000ng/L). The lowest hsTnT level
associated with the presence of LGE was 15ng/L. 83 of
106 (79%) patients underwent coronary angiography.
The mean indexed LVEDV 94mls/m2 (42-243) and
mean LVEF 54% (15-77). LGE was present in 69 of 106
CMR studies with a midwall/subepicardial distribution
most common (n=50). Myocarditis was the most com-
mon final clinical diagnosis (n=39), 77% (n= 30) with
LGE.
Clinical follow-up data was available for 103 patients.
There were 36 hospital admissions in 23 patients for
reasons including chest pain (n=9), arrhythmia/palpita-
tions (n=9), heart failure (n=2) and recurrent myocardi-
tis (n=2). 17% (n=12) of patients with LGE had a
hospital readmission compared to 27% (n10) of patients
who did not have LGE. One patient with LGE and one
without LGE died from non-cardiac causes.
Conclusions
CMR does not yield abnormal LGE in one-third of
patients with raised hsTnT not attributed to acute cor-
onary syndromes. One in four patients without LGE
were readmitted within one year and this rate is similar
to patients with LGE. Newer CMR techniques to
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evaluate for myocardial edema, fibrosis and necrosis
with higher sensitivity are needed.
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